Note: Ingredients listed on restricted chemical lists
EC/CAS
203-905-0/111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
<2
EC/CAS
202-860-4/100-52-7
Name of the chemical
benzaldehyde
Concentration
<0.2
EC/CAS
201-134-4/78-70-6
Name of the chemical
1,6-Octadien-3-ol, 3,7-dimethyl
Concentration
≤0.032
EC/CAS
202-589-1/97-53-0
Name of the chemical
eugenol
Concentration
<0.01
EC/CAS
227-813-5/5989-27-5
Name of the chemical
(R)-p-mentha-1,8-diene
Concentration
<0.008
EC/CAS
911-418-6/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.0015
General Information
Version
1.6
Revision date
2024-05-28
Product name
FARECLA G3 PRO WHEEL CLEANER
1.2.2. Uses advised against
This material should not be used for any other purpose than the identified uses without expert advice. Improper use may cause potential health, safety and environmental risks
supplier name
Farecla Products Limited
Manufacturer Name
Farecla Products Limited
Emergency telephone
+44 (0)19 2046 5041, +353 1 809 2566, +353 1 809 2166, +972 4 854 1900, +356 2545 6508, 0344 892 0111
Icons in SDS
Company Information
company name
Farecla Products Limited
e-mail address of the competent person responsible for the Safety Data Sheet
technical@farecla.com, -ehs.coating-solutions@saint-gobain.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
Adverse physicochemical, human health and environmental effects
Causes serious eye damage. Causes skin irritation. Harmful to aquatic life with long lasting effects. May cause an allergic skin reaction.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Contains
Sodium mercaptoacetate; Sodium Lauryl Ether Sulfate; Sodium (C14-16) olefin sulfonate; Sulfonic acids, C14-17-sec-alkane, sodium salts; Hexyl D-glucoside; 5-Chloro-2-methyl- 3(2H)-isothiazolone, mixture with 2-methyl-3(2H)-isothiazolone
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage.
Precautionary statements
P102 - Keep out of reach of children. P261 - Avoid breathing mist, vapours. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor. Nordic countries regulation Denmark Danish product registration number : PR - 4341735 MAL code : 00-3 (Executive Order No. 301 from 1993)
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Sodium mercaptoacetate (367-51-1), Sodium Lauryl Ether Sulfate (68891-38-3), 5-Chloro- regulation, in accordance with Annex XIII 2-methyl-3(2H)-isothiazolone, mixture with 2-methyl-3(2H)-isothiazolone (55965-84-9)(¹), Sodium Nitrate (7631-99-4)(¹) Substance(s) not meeting the vPvB criteria of REACH Sodium mercaptoacetate (367-51-1), Sodium Lauryl Ether Sulfate (68891-38-3), 5-Chloro- regulation, in accordance with Annex XIII 2-methyl-3(2H)-isothiazolone, mixture with 2-methyl-3(2H)-isothiazolone (55965-84-9)(¹), Sodium Nitrate (7631-99-4)(¹) (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
